{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:08:30Z","timestamp":1784038110910,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.urology.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:12:56Z","timestamp":1776172376000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of Patient, Disease, and Socioeconomic Characteristics With Receipt of Intravesical Bacillus Calmette-Gu\u00e9rin Therapy From 2002-2017 and the Impact of BCG Supply Shortages"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9927-6391","authenticated-orcid":false,"given":"David","family":"Kennedy-Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Almohtasib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedh","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Fleishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Korets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria F.","family":"Olumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Gershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.04.010_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA\u00a0Cancer J\u00a0Clin"},{"key":"10.1016\/j.urology.2026.04.010_bib2","first-page":"242","article-title":"Demographic and survivorship disparities in non\u2013muscle-invasive bladder cancer in the United States","volume":"51","author":"Seo","year":"2018","journal-title":"J\u00a0Prev\u00a0Med\u00a0Public Health"},{"key":"10.1016\/j.urology.2026.04.010_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cncr.24701","article-title":"Racial differences in treatment and outcomes among patients with early stage bladder cancer","volume":"116","author":"Hollenbeck","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"255.e15","DOI":"10.1016\/j.urolonc.2022.11.005","article-title":"Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer","volume":"41","author":"Estevez","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.04.010_bib6","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.clgc.2019.01.007","article-title":"Determinants of guideline-based treatment in patients with cT1 bladder cancer","volume":"17","author":"Balakrishnan","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/BLC-179018","article-title":"The BCG shortage","volume":"3","author":"Messing","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2026.04.010_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urology.2023.02.044","article-title":"Variation in statewide intravesical treatment rates for non-muscle invasive bladder cancer during the Bacillus Calmette-Guerin\u00a0drug shortage","volume":"177","author":"Chun","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.04.010_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.urology.2018.07.055","article-title":"Utilization of Bacillus Calmette-Guerin for nonmuscle invasive bladder cancer in an era of Bacillus Calmette-Guerin supply shortages","volume":"124","author":"Khanna","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.04.010_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.urology.2025.07.039","article-title":"Treatment patterns for non-muscle invasive bladder cancer during the Bacillus Calmette-Guerin shortage","volume":"205","author":"Obiora","year":"2025","journal-title":"Urology"},{"issue":"6_Suppl","key":"10.1016\/j.urology.2026.04.010_bib12","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.urology.2026.04.010_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eururo.2016.03.015","article-title":"Impact of prostate-specific antigen (PSA) screening trials and revised PSA screening guidelines on rates of prostate biopsy and postbiopsy complications","volume":"71","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2023-062482","article-title":"The 2022 to 2023 amoxicillin shortage and acute otitis media treatment","volume":"152","author":"Brewster","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.urology.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib16","first-page":"3734","article-title":"American Urological Association issues guidelines on the management of bladder cancer","volume":"61","author":"Morey","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.urology.2026.04.010_bib17","unstructured":"Association AU. BCG Shortage Info. \u3008https:\/\/www.auanet.org\/about-us\/bcg-shortage-info\u3009."},{"key":"10.1016\/j.urology.2026.04.010_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a\u00a0global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.urology.2026.04.010_bib19","first-page":"520","article-title":"Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project","volume":"180","author":"Huang","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1002\/cncr.26198","article-title":"Compliance with guidelines for patients with bladder cancer","volume":"117","author":"Chamie","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.04.010_bib21","doi-asserted-by":"crossref","first-page":"440.e11","DOI":"10.1016\/j.urolonc.2025.02.004","article-title":"The impact of age on BCG treatment response","volume":"43","author":"Tavelli","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.04.010_bib22","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1007\/s00345-020-03130-1","article-title":"Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer","volume":"38","author":"Krajewski","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"21.e21","DOI":"10.1016\/j.urolonc.2023.09.010","article-title":"Bacillus Calmette-Guerin (BCG) therapy is safe and effective in non-muscle invasive bladder cancer (NMIBC) patients with immunomodulating conditions","volume":"42","author":"Durant","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.eururo.2014.05.033","article-title":"The effect of age on the efficacy of maintenance bacillus Calmette-Gu\u00e9rin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911","volume":"66","author":"Oddens","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib25","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.33792","article-title":"The impact of the social construct of race on outcomes among bacille Calmette-Gu\u00e9rin-treated patients with high-risk non-muscle\u2013invasive bladder cancer in an equal-access setting","volume":"127","author":"Lawler","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.04.010_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canep.2016.04.012","article-title":"Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system","volume":"42","author":"Schinkel","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.urology.2026.04.010_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.urology.2019.03.035","article-title":"Care quality and variability in the use of intravesical therapy for initial treatment of nonmuscle invasive bladder cancer within a large, diverse integrated delivery system","volume":"131","author":"Danforth","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.04.010_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Gu\u00e9rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.04.010_bib29","first-page":"140","article-title":"Low-dose versus standard-dose bacille Calmette\u2013Gu\u00e9rin for non-muscle-invasive bladder cancer: systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Choi","year":"2022","journal-title":"Investig\u00a0Clin\u00a0Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:41:41Z","timestamp":1784036501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S0090429526002414"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.04.010","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Patient, Disease, and Socioeconomic Characteristics With Receipt of Intravesical Bacillus Calmette-Gu\u00e9rin Therapy From 2002-2017 and the Impact of BCG Supply Shortages","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}